Comment on

• International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

  Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Büschenfelde KH, Zeniya M, et al. Alvarez F, et al. J Hepatol. 1999 Nov;31(5):929-38. doi: 10.1016/s0168-8278(99)80297-9. J Hepatol. 1999. PMID: 10580593 No abstract available.
• The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study.

  Bernal W, Ma Y, Smith HM, Portmann B, Wendon J, Vergani D. Bernal W, et al. J Hepatol. 2007 Nov;47(5):664-70. doi: 10.1016/j.jhep.2007.05.011. Epub 2007 Jun 11. J Hepatol. 2007. PMID: 17602781
• The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice.

  Björnsson E, Davidsdottir L. Björnsson E, et al. J Hepatol. 2009 Mar;50(3):511-7. doi: 10.1016/j.jhep.2008.10.021. Epub 2008 Dec 25. J Hepatol. 2009. PMID: 19155082
• Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.

  Donaldson PT, Daly AK, Henderson J, Graham J, Pirmohamed M, Bernal W, Day CP, Aithal GP. Donaldson PT, et al. J Hepatol. 2010 Dec;53(6):1049-53. doi: 10.1016/j.jhep.2010.05.033. Epub 2010 Aug 1. J Hepatol. 2010. PMID: 20800921
• Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.

  Lucena MI, Kaplowitz N, Hallal H, Castiella A, García-Bengoechea M, Otazua P, Berenguer M, Fernandez MC, Planas R, Andrade RJ. Lucena MI, et al. J Hepatol. 2011 Oct;55(4):820-7. doi: 10.1016/j.jhep.2010.12.041. Epub 2011 Feb 19. J Hepatol. 2011. PMID: 21338638